Kyung Hoon Lee

Dr. Kyung Hoon Lee


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2000 in Neuroscience Letters
Verified
Journal Article
Closed access
DSDong Hoon Shin
Dong Hoon Shin
HLHyoung Soo Lim
Hyoung Soo Lim
SCSung Kyun Cho
Sung Kyun Cho
HLHwayoung Lee
Hwayoung Lee
HLHye Won Lee
Hye Won Lee
DHDouk Ho Hwang
Douk Ho Hwang

31 May 2022 in Stem Cells International
Verified
Journal Article
Open access
PDF file
Hyuk SongHyuk Song
Hyuk Song
HPHyun Jung Park
Hyun Jung Park
WLWon-Young Lee
Won-Young Lee
KLKyung Hoon Lee
Kyung Hoon Lee
Spermatogonial stem cells (SSCs) are the germline stem cells that are essential for the maintenance of spermatogenesis in the testis. However, it has not been sufficiently understood in amphibians, reptiles, and fish because numerous studies have been focused mainly on mammals. The aim of this review is to discuss scientific ways to elucidate SSC models of nonmammals in the context of the evolution of testicular organization since rodent SSC models. To further understand the SSC models in nonmammals, we point out common markers of an SSC pool (undifferentiated spermatogonia) in various types of testes where the kinetics of the SSC pool appears. This review includes the knowledge of (1) common molecular markers of vertebrate type A spermatogonia including putative SSC markers, (2) localization of the markers on the spermatogonia that have been reported in previous studies, (3) highlighting the most common markers in vertebrates, and (4) suggesting ways of finding SSC models in nonmammals.

1 January 2025 in Brazilian Archives of Biology and Technology
Verified
Journal Article
Open access
PDF file
FSFerry Sandra
Ferry Sandra
WRWiryadani Rahayu
Wiryadani Rahayu
IAIan Anthony
Ian Anthony
MLMiranti Anggorodhiyu Lokantari
Miranti Anggorodhiyu Lokantari
SASheila Annisa
Sheila Annisa
KLKyung Hoon Lee
Kyung Hoon Lee
Inositol hexakisphosphate (InsP6) requires relatively high concentrations to induce apoptosis of cancer cells, which can possibly cause apoptosis of normal cells. Anticancer ability of InsP6 could be preserved by combining with histone, so InsP6 can be used at low concentrations. The effect of InsP6 and histone combination has not been investigated on nasopharyngeal cancer cells. The current study elucidated the effect of InsP6 and its combination with histone on the apoptosis of HONE-1 cells. The most effective concentration and the cellular mechanisms by which this combination exerts its anticancer effects were also investigated. HONE-1 and NIH3T3 cells (as normal control cells) were treated with InsP6 and/or histone in different concentrations. Apoptosis percentages of the treated cells were measured with sub-G1 assay. Nuclear fragmentation and mitochondrial membrane potential (∆Ψm) reduction in the treated HONE-1 cells were confirmed with 4',6-diamidino-2-phenylindole (DAPI) staining and ∆Ψm assay, respectively. The combination of 10 μM InsP6 and 10 μg/mL histone had the optimal ability to induce the apoptosis of HONE-1 cells. This combination did not induce apoptosis of NIH3T3 cells. The apoptosis-inducing ability of this combination was higher than that of 10 μM InsP6 merely. The ability of InsP6 to induce apoptosis of HONE-1 cells could be enhanced by histone application. Combination of 10 μM InsP6 and 10 μg/mL histone might be the optimal concentrations for inducing apoptosis in HONE-1 cells.

31 December 2023 in Journal of Animal Reproduction and Biotechnology
Verified
Journal Article
Open access
PDF file
MHMingi Han
Mingi Han
RLRAN LEE
RAN LEE
HPHyun Jung Park
Hyun Jung Park
KLKyung Hoon Lee
Kyung Hoon Lee
Hyuk SongHyuk Song
Hyuk Song
Min-Gi Han, Ran Lee, Hyun Jung Park, Kyung Hoon Lee and Hyuk Song. Journal of Animal Reproduction and Biotechnology 2023;38:225-35. https://doi.org/10.12750/JARB.38.4.225

1 January 2026 in International Journal of Microbiology
Verified
Journal Article
Open access
FSFerry Sandra
Ferry Sandra
ASAlifah Evi Scania
Alifah Evi Scania
NDNurrani Mustika Dewi
Nurrani Mustika Dewi
DRDewi Ranggaini
Dewi Ranggaini
JHJohni Halim
Johni Halim
KLKyung Hoon Lee
Kyung Hoon Lee
The coevolution of the human diet and gut microbiome has played a pivotal role in shaping metabolic, immune, and epigenetic functions across human history. Dietary transitions from high‐fiber ancestral patterns to modern ultraprocessed diets have markedly influenced microbial diversity and functionality, contributing to the emergence of chronic diseases such as obesity, Type 2 diabetes, and inflammatory conditions. Recognizing the significance of gut microbial patterns in humans, this review explores the coevolution of diet and gut microbiota, especially on how gut microbiota influences human gene regulation, and the implications of these interactions for personalized nutrition and global health strategies. Comparative insights across populations in different periods reveal that geography, dietary practices, and host genetics interact to shape distinct microbiome configurations and disease susceptibility. Therefore, implementing a nutrigenomics and nutrigenetics approach might provide a molecular framework to understand these interactions and to develop personalized nutrition strategies. Though several clinical implementations utilizing genomic data have been embedded in several countries, global implementation remains challenging due to population‐specific genetic variability, cultural dietary preferences, cost limitations, and ethical considerations. Integrating microbiome and genetic data into clinical practice and public health policy offers a promising path to mitigate diet‐related health disparities that is tailored to individual and population‐level needs.

1 January 2025 in Narra J
Verified
Journal Article
Open access
PDF file
FSFerry Sandra
Ferry Sandra
THTiffany Hartono
Tiffany Hartono
RHRia A. Hayuningtyas
Ria A. Hayuningtyas
Dewi RanggainiDewi Ranggaini
Dewi Ranggaini
JHJohni Halim
Johni Halim
KLKyung Hoon Lee
Kyung Hoon Lee
Recent advances in cancer treatment have focused on developing alternative therapies with reduced adverse effects. Chemoprevention using natural products derived from plants has gained significant attention. Apium graveolens has demonstrated anticancer properties against various cancer cell types, suggesting its potential efficacy against tongue cancer cells. The aim of this study was to evaluate the cytotoxic effects and mechanisms of action of Apium graveolens leaf ethanolic extract (AGLEE) on the HSC-3 tongue cancer cell line. The leaves were processed and extracted with 70% ethanol to obtain an ethanolic extract. HSC-3 cells were cultured, subjected to starvation, and pre-treated with or without Z-DEVD-FMK, a caspase-3 inhibitor. Subsequently, the cells were treated with or without doxorubicin or varying concentrations of AGLEE. To assess cell viability and apoptosis, MTT and sub-G1 assays were performed. Additionally, treated HSC-3 cells were collected, lysed, and analyzed for levels of cleaved-caspase-3 and cleaved-poly (ADP-ribose) polymerase (cleaved-PARP) using ELISA. The inhibitory concentration (IC50) value of AGLEE for reducing viable HSC-3 cells was determined to be 48.29 μg/mL. AGLEE significantly decreased HSC-3 cell viability and increased the percentage of apoptotic cells. It exhibited a concentration-dependent reduction in cell viability and an increase in apoptosis. Furthermore, the extract elevated the levels of cleaved-caspase-3 and cleaved-PARP in HSC-3 cells. Pre-treatment with Z-DEVD-FMK reduced the levels of cleaved-caspase-3 and cleaved-PARP induced by AGLEE. Taken together, AGLEE could be proposed as a potential natural therapeutic agent by inducing apoptosis through the caspase-3/PARP pathway in tongue cancer cells.